<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="4419">
  <stage>Registered</stage>
  <submitdate>23/04/2014</submitdate>
  <approvaldate>23/04/2014</approvaldate>
  <nctid>NCT02126189</nctid>
  <trial_identification>
    <studytitle>The Princess Alexandra Hospital and the QIMR Berghofer Medical Research Institute Head and Neck Cancer Study</studytitle>
    <scientifictitle>An Epidemiological Study of Mucosal Squamous Cell Carcinomas of the Head and Neck</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>HREC13QPAH36</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Head and Neck Squamous Cell Carcinoma</healthcondition>
    <healthcondition>Human Papillomavirus</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Non melanoma skin cancer</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Kidney</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Head and neck</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Head and neck cancer - All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia are invited to participate.

</interventions>
    <comparator />
    <control />
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>To identify exposures associated with an increased risk of head and neck squamous cell carcinoma</outcome>
      <timepoint>2 years</timepoint>
    </primaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>-  All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra
             Hospital Brisbane Australia.</inclusivecriteria>
    <inclusiveminage />
    <inclusiveminagetype>No limit</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria />
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate />
    <actualstartdate>1/11/2013</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize>600</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate>1/11/2016</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Princess Alexandra Hospital - Brisbane</hospital>
    <postcode>4102 - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Queensland Centre of Excellence for Head and Neck Cancer</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>QIMR Berghofer Medical Research Institute</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Princess Alexandra Hospital, Brisbane, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Translational Research Institute, Brisbane, Australia</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>The University of Queensland</othercollaboratorname>
      <othercollaboratoraddress />
      <othercollaboratorcountry />
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is designed to refine the aetiological causes of cancers of the head and neck and
      investigate the ways in which human papillomavirus and life-style factors cause head and neck
      cancers. This study will determine if these factors affect the treatment of cancer.

      All patients attending the Head and Neck Clinic at the Princess Alexandra Hospital is invited
      to complete a risk factor questionnaire and give consent for their clinical data and tissue
      samples to be available for future research activities. The risk factor questionnaire is
      based on existing validated instruments developed by the QIMR Berghofer Medical Research
      Institute Cancer Control Group, and will collect standardised information relating to
      demographics and causal factors (tobacco and alcohol intake), risk modifiers (dentition,
      asprin and non-steroidal anti-inflammatory drugs (NSAIDS), height, weight, physical activity,
      diet quality etc) and behaviours (oral sex etc)</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT02126189</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Annika Antonsson, Dr</name>
      <address>QIMR Berghofer Medical Research Institute</address>
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name>Dana Middleton</name>
      <address />
      <phone>61 7 3176 3219</phone>
      <fax />
      <email>dana.middleton@health.qld.gov.au</email>
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>